N/A
Manufactured by Oyster Point Pharma, Inc.
10,186 FDA adverse event reports analyzed
Last updated: 2026-04-15
VARENICLINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Oyster Point Pharma, Inc.. The most commonly reported adverse reactions for VARENICLINE include SNEEZING, NAUSEA, DRUG INEFFECTIVE, VOMITING, DEPRESSION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for VARENICLINE.
Out of 5,760 classified reports for VARENICLINE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 10,186 FDA FAERS reports that mention VARENICLINE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include SNEEZING, NAUSEA, DRUG INEFFECTIVE, VOMITING, DEPRESSION, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Oyster Point Pharma, Inc. in connection with VARENICLINE. Always verify the specific product and NDC with your pharmacist.